Stockscreener 앱 받기
0.92
3.35%
0.0298
시간 외 거래:
.94
0.02
+2.17%
전일 마감가:
$0.8902
열려 있는:
$0.9571
하루 거래량:
120.15K
Relative Volume:
1.26
시가총액:
$15.34M
수익:
$3.20M
순이익/손실:
$-10.90M
주가수익비율:
-1.3654
EPS:
-0.6738
순현금흐름:
$-7.92M
1주 성능:
-3.16%
1개월 성능:
-21.37%
6개월 성능:
-41.77%
1년 성능:
-12.38%
1일 변동 폭
$0.88
$0.9595
1주일 범위
$0.88
$1.03
52주 변동 폭
$0.84
$2.46
마커 테라퓨틱스 Stock (MRKR) Company Profile
명칭
Marker Therapeutics Inc
전화
(713) 400-6400
주소
2450 HOLCOMBE BLVD, HOUSTON, TX
Compare MRKR vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
0.92 | 15.34M | 3.20M | -10.90M | -7.92M | -0.6738 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
마커 테라퓨틱스 Stock (MRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 개시 | Canaccord Genuity | Buy |
| 2021-03-25 | 개시 | Piper Sandler | Overweight |
| 2021-03-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | 개시 | ROTH Capital | Buy |
| 2019-03-01 | 개시 | Janney | Buy |
| 2018-12-03 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
마커 테라퓨틱스 주식(MRKR)의 최신 뉴스
Cerenome (Nasdaq:CNSY)Análisis de acciones - Simply Wall Street
Marker Therapeutics, Inc. Highlights Expanded Manufacturing Capabilities Supporting Mt-601 - marketscreener.com
Electra Therapeutics (ETRA) pursues IPO as auditor raises going-concern warning - Stock Titan
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight - Business Upturn
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight - The Manila Times
Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeIV Rank - dars.gov.et
Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeVolume Spike Alerts - siam.in
Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeUndervalued Stocks - dars.gov.et
Marker Therapeutics Inc. (MRKR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Is Marker Therapeutics (NASDAQ:MRKR) In A Good Position To Deliver On Growth Plans? - webull.com
Is Marker Therapeutics (NASDAQ:MRKR) In A Good Position To Deliver On Growth Plans? - Simply Wall Street
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com India
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com UK
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy - Investing.com
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportIchimoku Kumo Twist - vinanet.vn
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportHidden Order - careplusvn.com
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportPrice Target - dars.gov.et
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportRTH Profile - dars.gov.et
Marker Therapeutics Stock Price Forecast. Should You Buy MRKR? - StockInvest.us
Marker Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
MRKR Advances 2.7% to $1.14 as Biotech Stock Holds Above Key SupportVanna Flow - vinanet.vn
Marker Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
MRKR Advances 2.7% to $1.14 as Biotech Stock Holds Above Key SupportSmart Money Flow Stocks - careplusvn.com
CCORF Maintains Marker Therapeutics(MRKR.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Stock List: Research Stocks from Around the World - GuruFocus
Marker Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Marker Therapeutics Inc (MRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseAnnual Financial Report - careplusvn.com
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseProfit Inflection Point - vinanet.vn
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurprisePeak Earnings Alert - dars.gov.et
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseBasic EPS Analysis - dars.gov.et
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates - Intellia Therapeutics
Cerenome (Nasdaq:CNSY)Aktienanalyse - Simply Wall Street
MRKR Q1 2026 Earnings: Narrower Loss Beats Estimates as Investors Focus on Clinical MilestonesGuidance Downgrade Alert - vinanet.vn
Marker Therapeutics, Inc. Revenue Breakdown – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc (MRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Marker Therapeutics Inc (MRKR) Balance Sheet - TradingKey
Marker Therapeutics Inc (MRKR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Marker Therapeutics Inc (MRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Marker Therapeutics Inc (MRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.200|Chg%:-0.020 - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.220|Chg%:-0.050 - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.200|Chg%:-0.020 - TradingKey
Marker Therapeutics Inc (MRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
US High Growth Tech Stocks to Watch for Potential Expansion - simplywall.st
마커 테라퓨틱스 (MRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.35%
자본화:
|
볼륨(24시간):